Initiative Capital Romandie
9
10M
5
0.44
1
- Areas of investment
Summary
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Viroblock, Diagnoplex, Endosense. Among the most successful fund investment fields, there are Personal Health, Medical Device. The fund has exact preference in some founders of portfolio startups.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Initiative Capital Romandie, startups are often financed by Neomed Management, Ysios Capital, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are BioMedPartners, BB Biotech Ventures, Neomed Management. In the next rounds fund is usually obtained by BioMedPartners, Banexi Ventures, BB Biotech Ventures.
The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Initiative Capital Romandie works on 15 percentage points less the average amount of lead investments. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2013.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.44
- Investments by industry
- Health Care (7)
- Medical Device (6)
- Biotechnology (4)
- Neuroscience (4)
- Health Diagnostics (4) Show 6 more
- Investments by region
-
- Switzerland (9)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 40M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| PicoDRILL | 01 Aug 2017 | Nanotechnology | Early Stage Venture | 6M | Switzerland, Vaud, Lausanne |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.